Briefly, oocytes were first fixed in 4% paraformaldehyde for 30 min at room temperature ... for the induction of oocyte meiotic resumption by the LH surge. Since granulosa cells cease dividing and ...
This valuable paper describes the stiffness of meiotic chromosomes ... at room temperature within 3 hours to minimize the effects of water evaporation from the culture well. MEF cells and ...
In a study published in Nature, researchers report the successful in vitro reconstitution of meiotic DNA double-strand breaks ...
Combining concepts from statistical physics with machine learning, researchers at the University of Bayreuth have shown that ...
Perovskite solar cells are highly efficient and low cost in production. However, they still lack stability over the decades under real weather conditions. An international research collaboration has ...
This valuable study reports on the critical role of ANKRD5 (ANKEF1) in sperm motility and male fertility. However, the supporting data remain incomplete. This work will be of interest to biomedical ...
In this article, we are going to take a look at where Tempus AI (NASDAQ:TEM) stands against the other stocks. Stock gains always get people talking, and 2025 is no exception. Markets have moved ...
Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14 ...
Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...
Tempus AI, Inc. TEM recently unveiled olivia, an artificial intelligence (AI)-driven health concierge app designed to assist patients in managing their health. With olivia, users can centralize ...
In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other large-cap stocks. We previously covered 10 Large-Cap Stocks Insiders Are Buying Recently.